|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM261968238 |
003 |
DE-627 |
005 |
20231224200731.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2016 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2016.06.009
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0873.xml
|
035 |
|
|
|a (DE-627)NLM261968238
|
035 |
|
|
|a (NLM)27368806
|
035 |
|
|
|a (PII)S1521-6616(16)30117-6
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Wang, Ninghai
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Slamf6 negatively regulates autoimmunity
|
264 |
|
1 |
|c 2016
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 31.05.2017
|
500 |
|
|
|a Date Revised 23.10.2019
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2016 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a The nine SLAM family (Slamf) receptors are positive or negative regulators of adaptive and innate immune responses, and of several autoimmune diseases. Here we report that the transfer of Slamf6-/- B6 CD4+ T cells into co-isogenic bm12 mice causes SLE-like autoimmunity with elevated levels of autoantibodies. In addition, significantly higher percentages of Tfh cells and IFN-γ-producing CD4+ cells, as well as GC B cells were observed. Interestingly, the expression of the Slamf6-H1 isoform in Slamf6-/- CD4+ T cells did not induce this lupus-like phenotype. By contrast, Slamf1-/- or Slamf5-/- CD4+ T cells caused the same pathology as WT CD4+ T cells. As the transfer of Slamf [1+6]-/- or Slamf [1+5+6]-/- CD4+ T cells induced WT levels of autoantibodies, the presence of Slamf1 was requisite for the induction of increased levels of autoantibodies by Slamf6-/- CD4+ T cells. We conclude that Slamf6 functions as an inhibitory receptor that controls autoimmune responses
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Autoantibody
|
650 |
|
4 |
|a GVH
|
650 |
|
4 |
|a Slamf6
|
650 |
|
4 |
|a Tfh cells
|
650 |
|
7 |
|a Autoantibodies
|2 NLM
|
650 |
|
7 |
|a Cd84 protein, mouse
|2 NLM
|
650 |
|
7 |
|a Signaling Lymphocytic Activation Molecule Family
|2 NLM
|
650 |
|
7 |
|a Slamf1 protein, mouse
|2 NLM
|
650 |
|
7 |
|a Slamf6 protein, mouse
|2 NLM
|
650 |
|
7 |
|a Signaling Lymphocytic Activation Molecule Family Member 1
|2 NLM
|
650 |
|
7 |
|a 169535-43-7
|2 NLM
|
650 |
|
7 |
|a Interferon-gamma
|2 NLM
|
650 |
|
7 |
|a 82115-62-6
|2 NLM
|
700 |
1 |
|
|a Keszei, Marton
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Halibozek, Peter
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yigit, Burcu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Engel, Pablo
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Terhorst, Cox
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 173(2016) vom: 01. Dez., Seite 19-26
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:173
|g year:2016
|g day:01
|g month:12
|g pages:19-26
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2016.06.009
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 173
|j 2016
|b 01
|c 12
|h 19-26
|